J. de Jong

521 total citations
15 papers, 420 citations indexed

About

J. de Jong is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J. de Jong has authored 15 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J. de Jong's work include Cancer Treatment and Pharmacology (6 papers), Cancer therapeutics and mechanisms (4 papers) and Lung Cancer Research Studies (3 papers). J. de Jong is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Cancer therapeutics and mechanisms (4 papers) and Lung Cancer Research Studies (3 papers). J. de Jong collaborates with scholars based in Switzerland, Italy and Germany. J. de Jong's co-authors include Cristiana Sessa, Olivia Pagani, R.N. Davidson, Jill Seaman, Carla J. de Boer, Robert J. Wilkinson, Egbert Sondorp, F. Cavalli, Michele Tomamichel and Franco Cavalli and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Infectious Diseases and British Journal of Cancer.

In The Last Decade

J. de Jong

14 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. de Jong Switzerland	12	155	131	116	67	48	15	420
Pam S. Dellea United States	8	84 0.5×	59 0.5×	48 0.4×	21 0.3×	35 0.7×	11	438
Greta Burmeister Germany	15	75 0.5×	178 1.4×	120 1.0×	31 0.5×	14 0.3×	22	512
Laura Andrews United States	15	48 0.3×	168 1.3×	73 0.6×	28 0.4×	36 0.8×	37	583
Elisabetta Valentini Italy	15	68 0.4×	250 1.9×	112 1.0×	28 0.4×	22 0.5×	24	496
William Roberts United States	16	126 0.8×	209 1.6×	89 0.8×	33 0.5×	37 0.8×	38	563
Lars Thaning Sweden	9	56 0.4×	105 0.8×	263 2.3×	111 1.7×	35 0.7×	11	410
Shawgi Sukumaran Australia	11	48 0.3×	133 1.0×	208 1.8×	38 0.6×	34 0.7×	44	407
Katherine B. Lee United States	8	101 0.7×	100 0.8×	71 0.6×	20 0.3×	25 0.5×	10	407
Michela Dalmartello Italy	12	168 1.1×	67 0.5×	146 1.3×	62 0.9×	13 0.3×	21	457

Countries citing papers authored by J. de Jong

Since Specialization

Citations

This map shows the geographic impact of J. de Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. de Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. de Jong more than expected).

Fields of papers citing papers by J. de Jong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. de Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. de Jong. The network helps show where J. de Jong may publish in the future.

Co-authorship network of co-authors of J. de Jong

This figure shows the co-authorship network connecting the top 25 collaborators of J. de Jong. A scholar is included among the top collaborators of J. de Jong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. de Jong. J. de Jong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Tomamichel, Michele, Herlinda Bonilla Jaime, J. de Jong, et al.. (2000). Proposing phase I studies: Patients', relatives', nurses' and specialists' perceptions. Annals of Oncology. 11(3). 289–294. 25 indexed citations

Ghielmini, Michele, Olivia Pagani, J. de Jong, et al.. (1999). Double-blind randomized study on the myeloprotective effect of melatonin in combination with carboplatin and etoposide in advanced lung cancer. British Journal of Cancer. 80(7). 1058–1061. 30 indexed citations

Sessa, Cristiana, Carla Minoia, A. Ronchi, et al.. (1998). Phase I clinical and pharmacokinetic study of the oral platinum analogue JM216 given daily for 14 days. Annals of Oncology. 9(12). 1315–1322. 45 indexed citations

Pagani, Olivia, Cristiana Sessa, Giovanni Martinelli, et al.. (1997). Dose-finding study of paclitaxel and cyclophosphamide in advanced breast cancer. Annals of Oncology. 8(7). 655–661. 11 indexed citations

Pagani, Olivia, Massimo Zucchetti, Cristiana Sessa, et al.. (1996). Clinical and pharmacokinetic study of oral NK611, a new podophyllotoxin derivative. Cancer Chemotherapy and Pharmacology. 38(6). 541–547. 24 indexed citations

Wolff, Ingmar, Jos H. Beijnen, U. Bruntsch, et al.. (1996). Phase I clinical and pharmacokinetic study of carzelesin (U-80244) given daily for five consecutive days.. PubMed. 2(10). 1717–23. 16 indexed citations

Zucchetti, Massimo, Olivia Pagani, Valter Torri, et al.. (1996). Clinical pharmacology of chronic oral etoposide in patients with small cell and non-small cell lung cancer. Lung Cancer. 15(1). 154–155. 11 indexed citations

Sessa, Cristiana, et al.. (1996). Phase I study of the antipurine antifolate lometrexol (DDATHF) with folinic acid rescue.. PubMed. 2(7). 1123–7. 14 indexed citations

Sessa, Cristiana, Massimo Zucchetti, T. Cerny, et al.. (1995). Phase I clinical and pharmacokinetic study of oral etoposide phosphate.. Journal of Clinical Oncology. 13(1). 200–209. 23 indexed citations

10.

Tomamichel, Michele, Cristiana Sessa, Stefan Herzig, et al.. (1995). Informed consent for phase I studies: Evaluation of quantity and quality of information provided to patients. Annals of Oncology. 6(4). 363–369. 59 indexed citations

11.

Seaman, Jill, Carla J. de Boer, Robert J. Wilkinson, et al.. (1995). Liposomal Amphotericin B (AmBisome) in the Treatment of Complicated Kala-Azar Under Field Conditions. Clinical Infectious Diseases. 21(1). 188–193. 90 indexed citations

12.

Sessa, Cristiana, Olivia Pagani, Maria Grazia Zurlo, et al.. (1994). Phase I study of the novel distamycin derivative tallimustine (FCE 24517). Annals of Oncology. 5(10). 901–907. 40 indexed citations

13.

Jong, J. de, et al.. (1994). Conclusions and Recommendations of the International Conference on Rehabilitation of the River Rhine March 15-19, 1993, Arnhem, The Netherlands. Water Science & Technology. 29(3). 387–390. 1 indexed citations

14.

Hupperets, P., Lex Volovics, Leo J. Schouten, et al.. (1993). Adjuvant chemohormonal therapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) with or without medroxyprogesterone acetate for node-positive breast cancer patients. Annals of Oncology. 4(4). 295–301. 17 indexed citations

15.

Kalken, C.K. van, Jacobus J. M. van der Hoeven, J. de Jong, et al.. (1991). Bepridil in combination with anthracyclines in the attempt to reverse anthracycline-resistance in cancer patients. European Journal of Cancer. 27(6). 739–744. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact